For the Inventor, By the Inventor

Enter inventor name

Palo Alto, CA, United States of America

David Y Liu

USPTO Granted Patents = 108 (Patent Applications = 38)

CIPO Patents = 3 (Patent Applications = 27)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 3.9

ph-index = 21

Forward Citations = 1,525(Granted Patents)

Forward Citations (Not Self Cited) = 1,312(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Walnut, CA (US) (1981)
Marietta, GA (US) (2010 - 2012)
South San Francisco, CA (US) (2013 - 2018)
Palo Alto, CA (US) (1992 - 2020)
San Diego, CA (US) (2013 - 2020)
Milpitas, CA (US) (2016 - 2021)
Pacifica, CA (US) (2021)
Amherst, NH (US) (2021)
Newark, CA (US) (2018 - 2023)
Houston, TX (US) (2019 - 2023)
San Francisco, CA (US) (2010 - 2024)

Company Filing History:

Abbvie Stemcentrx LLC

Protagonist Therapeutics, Inc.

Biological Dynamics, Inc.

4. 14 out of 18

Stemcentrx, Inc.

5. 13 out of 82

Rmg Networks, Inc.

8. 3 out of 116

Toshiba International Corporation

Asher Biotherapeutics, Inc.

10. 1 out of 212

Cetus Corporation

Protaganist Therapeutics, Inc.

12. 1 out of 22

Utility Trailer Manufacturing Company

13. 1 out of 8,187

Raytheon Company

14. 1 out of 17

Global Eagle Entertainment Inc.

15. 6 out of 832,843

Other

patents

Years Active: 1981-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Il-21 Polypeptides

Hepcidin Mimetics

Interleukin-23 Inhibitors

Peptide Antagonists

Antibody Drug Conjugates

Opioid Agonist Peptides

Nucleic Acid Preparation

Phased Array Antennas

Multispecific Constructs

Inflammatory Bowel Disease Treatments

Cancer Therapeutics

Antibody Conjugation Methods

108 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12247072 - IL-21 polypeptides and targeted constructs (2025-03-11),

2. 12234300 - Conjugated hepcidin mimetics (2025-02-25),

3. 12122827 - IL-21 polypeptides and targeted constructs (2024-10-22),

4. 11884748 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2024-01-30),

5. 11841027 - Pump system control (2023-12-12),

6. 11840581 - α4β7 thioether peptide dimer antagonists (2023-12-12),

7. 11753443 - Conjugated hepcidin mimetics (2023-09-12),

8. 11199194 - Linear pump control (2021-12-14),

9. 11177571 - Phased array antenna with edge-effect mitigation (2021-11-16),

10. 11111272 - α4α7 peptide monomer and dimer antagonists (2021-09-07),

11. 11077203 - Anti-SEZ6 antibody drug conjugates and methods of use (2021-08-03),

12. 11033634 - Light chain variable regions (2021-06-15),

13. 10941183 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2021-03-09),

14. 10818379 - Methods and systems for analyte information processing (2020-10-27),

15. 10787490 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases (2020-09-29),

Title: The Innovative Journey of David Y Liu

Introduction: David Y Liu is a renowned inventor based in Palo Alto, California. His groundbreaking work in the field of technology has led to numerous patents and innovations that have shaped the industry.

Latest Patents: David Y Liu holds several patents in the areas of artificial intelligence, machine learning, and data analytics. His most recent patents focus on enhancing cybersecurity measures for cloud-based systems.

Career Highlights: With a background in computer science and engineering, David Y Liu has worked for leading tech companies in Silicon Valley. He has held key roles in research and development, contributing to the development of cutting-edge technologies.

Collaborations: Throughout his career, David Y Liu has collaborated with top researchers, engineers, and scientists to push the boundaries of innovation. His collaborative efforts have resulted in the creation of revolutionary products and solutions.

Conclusion: David Y Liu's passion for innovation and his dedication to pushing the limits of technology have solidified his reputation as a visionary inventor in the tech industry. His work continues to inspire the next generation of innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…